You are here

vaccines

J&J, erring on caution, tests new 2-dose regimen for COVID-19 vaccine

J&J, erring on caution, tests new 2-dose regimen for COVID-19 vaccine

Fierce Biotech

clinical trials

Flag link:

Inovio Jumps on Progress of Coronavirus Vaccine Candidate

Inovio Jumps on Progress of Coronavirus Vaccine Candidate

TheStreet.com

clinical trials

Flag link:

J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial

J&J taps into BARDA well a third time to speed up its PhIII Covid-19 vaccine trial

Endpoints

clinical trials

Flag link:

[video+transcript]How Long Will It Take for Coronavirus Vaccines to Help the U.S. Move Past the Pandemic?

[video+transcript]How Long Will It Take for Coronavirus Vaccines to Help the U.S. Move Past the Pandemic?

Motley Fool

Flag link:

COVID-19 tracker: Melatonin emerges as promising COVID treatment; Warp Speed chief Slaoui seeks Trump's OK to brief Biden team

COVID-19 tracker: Melatonin emerges as promising COVID treatment; Warp Speed chief Slaoui seeks Trump's OK to brief Biden team

Fierce Pharma

Operation Warp Speed

Gilead Sciences

Flag link:

Can Pfizer's COVID-19 Vaccine End the Pandemic? BioNTech's CEO Believes So

Can Pfizer's COVID-19 Vaccine End the Pandemic? BioNTech's CEO Believes So

BioSpace

Flag link:

What if Moderna Doesn't Win the Coronavirus Vaccine Race?

What if Moderna Doesn't Win the Coronavirus Vaccine Race?

Motley Fool

Moderna Therapeutics

Flag link:

J&J tops list of healthcare supply chains amid COVID vaccine effort—and Pfizer wins kudos, too

J&J tops list of healthcare supply chains amid COVID vaccine effort—and Pfizer wins kudos, too

Fierce Pharma

Flag link:

Pfizer says placebo patients will eventually get its Covid-19 vaccine. The question of when is complicated

Pfizer says placebo patients will eventually get its Covid-19 vaccine. The question of when is complicated

Stat

clinical trials

Flag link:

New Animal Data Shows Promise for Vaxart’s Oral COVID-19 Vaccine

New Animal Data Shows Promise for Vaxart’s Oral COVID-19 Vaccine

BioSpace

Flag link:

CureVac flags its COVID-19 vaccine as being suitable for standard refrigeration

CureVac flags its COVID-19 vaccine as being suitable for standard refrigeration

Biopharma Reporter

Flag link:

Johnson & Johnson confident in 1B dose goal for COVID vaccine next year, looking ahead to 2022

Johnson & Johnson confident in 1B dose goal for COVID vaccine next year, looking ahead to 2022

Fierce Pharma

drug manufacturing

Flag link:

Tapping GSK tech, Medicago kickstarts later-stage COVID vax tests

Tapping GSK tech, Medicago kickstarts later-stage COVID vax tests

Fierce Biotech

clinical trials

Flag link:

Amid cold chain blues, Pfizer looks to powder vaccine formula in 2021: report

Amid cold chain blues, Pfizer looks to powder vaccine formula in 2021: report

Fierce Pharma

powder vaccine formula

Flag link:

Pfizer's COVID-19 vaccine looks impressive, but Sanofi, J&J and Novavax shots eye a logistics edge

Pfizer's COVID-19 vaccine looks impressive, but Sanofi, J&J and Novavax shots eye a logistics edge

Fierce Pharma

Flag link:

Moderna says it's reached the required number of Covid-19 cases for its first interim analysis. When is the readout coming?

Moderna says it's reached the required number of Covid-19 cases for its first interim analysis. When is the readout coming?

Endpoints

Moderna Therapeutics

clinical trials

Flag link:

Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly legally—as COVID vaccine data lifts market

Lucky Pfizer CEO Bourla cashes out $5.6M worth of stock—perfectly legally—as COVID vaccine data lifts market

Fierce Pharma

Flag link:

Pfizer, BioNTech ink multibillion-dollar EU deal for up to 300M doses of COVID-19 vaccine

Pfizer, BioNTech ink multibillion-dollar EU deal for up to 300M doses of COVID-19 vaccine

Fierce Pharma

Flag link:

ImmunityBio, NantKwest announce positive interim phase 1 safety data of hAd5 Covid-19 vaccine dose study

ImmunityBio, NantKwest announce positive interim phase 1 safety data of hAd5 Covid-19 vaccine dose study

Pharmaceutical Business Review

clinical trials

Flag link:

A cancer vaccine that might work? Moderna posts 'promising' early snapshot for Merck-partnered program and raids Bristol Myers for a new cancer R&D chief

A cancer vaccine that might work? Moderna posts 'promising' early snapshot for Merck-partnered program and raids Bristol Myers for a new cancer R&D chief

Endpoints

Moderna Therapeutics

cancer vaccines

Bristol-Myers Squibb

Flag link:

Pages